Kirsten Maria Jansen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Kirsten Maria Jansen has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
- Terje S. Larsen
Cardiovascular Research Group, Department of Medical Biology, UiT—The Arctic University of Norway, 9019 Tromsø, Norway
2 shared publications - Alice M. Pedersen
Calanus AS, Kystens Hus, Stortorget 1, 9008 Tromsø, Norway
1 shared publication - Jakub Mrázek
Laboratory of Anaerobic Microbiology, Institute of Animal Physiology and Genetics, Czech Academy of Science, 14220 Prague, Czech Republic
1 shared publication - Pablo Miguel Garcia-Roves
University of Barcelona
1 shared publication - Pauke Carlijn Schots
Faculty of Biosciences, Norwegian College of Fishery Science, Fisheries and Economics, UiT-The Arctic University of Norway, 9037 Tromsø, Norway
1 shared publication - Ragnar L. Olsen
Norwegian College of Fishery Science, UiT The Arctic University of Norway, Tromsø, Norway
1 shared publication
Latest Publications
- Open Access
- 1 January 2021
- Published by XMLink in Journal of Lipid and Atherosclerosis
- Vol. 10 (1) , 8-23
Impact of Obesity-Related Inflammation on Cardiac Metabolism and Function
Larsen TS, et al. J Lipid Atheroscler. 2021 Jan;10(1):8-23. https://doi.org/10.12997/jla.2021.10.1.8
- 1 January 2021
- Published by XMLink in Journal of Lipid and Atherosclerosis
- Vol. 10 (1) , 8-23
Open AccessImpact of Obesity-Related Inflammation on Cardiac Metabolism and Function
Larsen TS, et al. J Lipid Atheroscler. 2021 Jan;10(1):8-23. https://doi.org/10.12997/jla.2021.10.1.8
- Open Access
- 1 November 2020
- Published by Elsevier in Nutrition Research
- Vol. 83, 94-107
Obesity-induced alterations in the gut microbiome in female mice fed a high-fat diet are antagonized by dietary supplementation with a novel, wax ester–rich, marine oil
- 1 November 2020
- Published by Elsevier in Nutrition Research
- Vol. 83, 94-107
Open AccessObesity-induced alterations in the gut microbiome in female mice fed a high-fat diet are antagonized by dietary supplementation with a novel, wax ester–rich, marine oil
- 1 August 2019
- Published by American Physiological Society in American Journal of Physiology-Heart and Circulatory Physiology
- Vol. 317 (2) , H290-H299
Dietary Calanus oil recovers metabolic flexibility and rescues postischemic cardiac function in obese female mice
The aim of this study was to find out whether dietary supplementation with Calanus oil (a novel marine oil) or infusion of exenatide (an incretin mimetic) could counteract obesity-induced alterations in myocardial metabolism and improve postischemic recovery of left ventricular (LV) function. Female C57bl/6J mice received high-fat diet (HFD, 45% energy from fat) for 12 wk followed by 8-wk feeding with nonsupplemented HFD, HFD supplemented with 2% Calanus oil, or HFD plus exenatide infusion (10 µg·kg−1·day−1). A lean control group was included, receiving normal chow throughout the whole period. Fatty acid and glucose oxidation was measured in ex vivo perfused hearts during baseline conditions, while LV function was assessed with an intraventricular fluid-filled balloon before and after 20 min of global ischemia. HFD-fed mice receiving Calanus oil or exenatide showed less intra-abdominal fat deposition than mice receiving nonsupplemented HFD. Both treatments prevented the HFD-induced decline in myocardial glucose oxidation. Somewhat surprising, recovery of LV function was apparently better in hearts from mice fed nonsupplemented HFD relative to hearts from mice fed normal chow. More importantly however, postischemic recovery of hearts from mice receiving HFD with Calanus oil was superior to that of mice receiving nonsupplemented HFD and mice receiving HFD with exenatide, as expressed by better pressure development, contractility, and relaxation properties. In summary, dietary Calanus oil and administration of exenatide counteracted obesity-induced derangements of myocardial metabolism. Calanus oil also protected the heart from ischemia, which could have implications for the prevention of obesity-related cardiac disease. NEW & NOTEWORTHY This article describes for the first time that dietary supplementation with a low amount (2%) of a novel marine oil (Calanus oil) in mice is able to prevent the overreliance of fatty acid oxidation for energy production during obesity. The same effect was observed with infusion of the incretin mimetic, exanatide. The improvement in myocardial metabolism in Calanus oil-treated mice was accompanied by a significantly better recovery of cardiac performance following ischemia-reperfusion. Listen to this article’s corresponding podcast at https://ajpheart.podbean.com/e/dietary-calanus-oil-energy-metabolism-and-cardiac-function/ .
- 1 August 2019
- Published by American Physiological Society in American Journal of Physiology-Heart and Circulatory Physiology
- Vol. 317 (2) , H290-H299
Dietary Calanus oil recovers metabolic flexibility and rescues postischemic cardiac function in obese female mice
The aim of this study was to find out whether dietary supplementation with Calanus oil (a novel marine oil) or infusion of exenatide (an incretin mimetic) could counteract obesity-induced alterations in myocardial metabolism and improve postischemic recovery of left ventricular (LV) function. Female C57bl/6J mice received high-fat diet (HFD, 45% energy from fat) for 12 wk followed by 8-wk feeding with nonsupplemented HFD, HFD supplemented with 2% Calanus oil, or HFD plus exenatide infusion (10 µg·kg−1·day−1). A lean control group was included, receiving normal chow throughout the whole period. Fatty acid and glucose oxidation was measured in ex vivo perfused hearts during baseline conditions, while LV function was assessed with an intraventricular fluid-filled balloon before and after 20 min of global ischemia. HFD-fed mice receiving Calanus oil or exenatide showed less intra-abdominal fat deposition than mice receiving nonsupplemented HFD. Both treatments prevented the HFD-induced decline in myocardial glucose oxidation. Somewhat surprising, recovery of LV function was apparently better in hearts from mice fed nonsupplemented HFD relative to hearts from mice fed normal chow. More importantly however, postischemic recovery of hearts from mice receiving HFD with Calanus oil was superior to that of mice receiving nonsupplemented HFD and mice receiving HFD with exenatide, as expressed by better pressure development, contractility, and relaxation properties. In summary, dietary Calanus oil and administration of exenatide counteracted obesity-induced derangements of myocardial metabolism. Calanus oil also protected the heart from ischemia, which could have implications for the prevention of obesity-related cardiac disease. NEW & NOTEWORTHY This article describes for the first time that dietary supplementation with a low amount (2%) of a novel marine oil (Calanus oil) in mice is able to prevent the overreliance of fatty acid oxidation for energy production during obesity. The same effect was observed with infusion of the incretin mimetic, exanatide. The improvement in myocardial metabolism in Calanus oil-treated mice was accompanied by a significantly better recovery of cardiac performance following ischemia-reperfusion. Listen to this article’s corresponding podcast at https://ajpheart.podbean.com/e/dietary-calanus-oil-energy-metabolism-and-cardiac-function/ .